ARE Alexandria Real Estate Equities

Q3 2025 10-Q

Filed: Oct 27, 2025Period ending Sep 30, 2025

Financials

Real Estate Investment TrustsSEC EDGAR

Alexandria Real Estate Equities Overview

Alexandria Real Estate Equities (ARE) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 27, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Management Discussion & Analysis

• Revenue not explicitly stated; FFO $377.8M, down 7.4% YoY from $407.9M for Q3 2024
• Net loss $234.9M vs net income $164.7M YoY for Q3; per share loss $(1.38) vs income $0.96

+4 more insights

Risk Factors

• Newly added risk: FDA laid off 3,500 employees (19% of workforce) in 2025 disrupting regulatory approvals and R&D timelines for tenants
• Most materially updated risk: NIH budget freeze reversed but FY2026 proposal cuts NIH funding by 40% from $48B to $27.5B impacting research funding

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$752M

Net Income

-$233M

Net Margin

-31.0%

ROE

-1.4%

Total Assets

$37.4B

Source: XBRL data from Alexandria Real Estate Equities Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Alexandria Real Estate Equities Quarterly Reports

Q2 2025 10-Q

Q1 2025 10-Q

Get deeper insights on Alexandria Real Estate Equities

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.